Recursion Pharmaceuticals, Inc.
RXRX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001601830
In the last 90 days, Recursion Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 344 institutions reported holding it in 13F filings for Q2 2026, worth $1.33B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2022
Institutional positions in Recursion Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 128
- +3 vs. Q4 2021
- Shares held
- 95.0M
- +697.7K (+0.7%) vs. Q4 2021
- Total value
- $680.3M
- −$936.2M (−57.9%) vs. Q4 2021
- New holders
- 24
- 40 more added
- Sold out
- 21
- 37 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RXRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 344 | $1.33B |
| Q1 2026 | 335 | $1.03B |
| Q4 2025 | 335 | $1.33B |
| Q3 2025 | 322 | $1.58B |
| Q2 2025 | 333 | $1.57B |
| Q1 2025 | 337 | $1.63B |
| Q4 2024 | 316 | $2.06B |
| Q3 2024 | 268 | $1.74B |
| Q2 2024 | 270 | $1.89B |
| Q1 2024 | 248 | $2.12B |
| Q4 2023 | 199 | $2.04B |
| Q3 2023 | 192 | $1.16B |
| Q2 2023 | 158 | $952.8M |
| Q1 2023 | 159 | $841.4M |
| Q4 2022 | 144 | $954.0M |
| Q3 2022 | 146 | $1.21B |
| Q2 2022 | 133 | $861.1M |
| Q1 2022 | 128 | $680.3M |
| Q4 2021 | 126 | $1.62B |
| Q3 2021 | 84 | $1.26B |
| Q2 2021 | 75 | $1.71B |
| Q1 2021 | 1 | $1.00K |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Recursion Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 495,152 | $3.54M | 0.00% | +461,323+1,363.7% | Added |
| Samsara BioCapital, LLC | 539,236 | $3.86M | 0.98% | 00.0% | Unchanged |
| Casdin Capital, LLC | 548,156 | $3.92M | 0.18% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 562,190 | $4.03M | 0.00% | −295,383−34.4% | Reduced |
| Northern Trust Corp | 859,544 | $6.15M | 0.00% | −26,417−3.0% | Reduced |
| Citadel Advisors LLC | 909,970 | $6.51M | 0.01% | +710,363+355.9% | Added |
| Comprehensive Financial Management LLC | 1,109,395 | $7.94M | 0.14% | 00.0% | Unchanged |
| Botty Investors LLC | 1,267,430 | $9.07M | 3.13% | +12,000+1.0% | Added |
| Geode Capital Management, LLC | 1,293,756 | $9.26M | 0.00% | −1,201−0.1% | Reduced |
| Massachusetts Financial Services Co | 1,336,750 | $9.57M | 0.00% | +36,709+2.8% | Added |
| MIC Capital Management UK LLP | 1,388,889 | $9.94M | 1.93% | 00.0% | Unchanged |
| Norges Bank | 1,397,275 | $10.0M | 0.00% | +10.0% | Added |
| Harvard Management Co Inc | 1,509,254 | $10.8M | 1.09% | 00.0% | Unchanged |
| Credit Suisse AG | 1,564,602 | $11.2M | 0.01% | +4,984+0.3% | Added |
| Two Sigma Ventures, LP | 1,806,800 | $12.9M | 74.73% | 00.0% | Unchanged |
| State Street Corp | 1,918,734 | $13.7M | 0.00% | −2,737,993−58.8% | Reduced |
| MV Management XI, L.L.C. | 1,971,908 | $14.1M | 9.80% | 00.0% | Unchanged |
| Platinum Investment Management Ltd | 2,136,604 | $15.3M | 0.47% | +692,741+48.0% | Added |
| FMR LLC | 2,145,639 | $15.4M | 0.00% | +615,413+40.2% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,827,163 | $20.2M | 0.08% | +595,150+26.7% | Added |
| Alliancebernstein L.P. | 3,380,718 | $24.2M | 0.01% | +504,899+17.6% | Added |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $28.3M | 31.54% | 00.0% | Unchanged |
| Laurion Capital Management LP | 4,587,274 | $32.8M | 0.78% | +663,561+16.9% | Added |
| Data Collective IV GP, LLC | 5,941,120 | $42.5M | 9.03% | 00.0% | Unchanged |
| Obvious Management Services, L.L.C. | 5,977,631 | $42.8M | 100.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 6,611,377 | $47.3M | 0.00% | +497,504+8.1% | Added |
| BlackRock Inc. | 6,707,757 | $48.0M | 0.00% | −54,927−0.8% | Reduced |
| Baillie Gifford & Co | 21,981,604 | $157.4M | 0.11% | −141,551−0.6% | Reduced |
| PointState Capital LP | 0 | $0 | 0.00% | −409,567−100.0% | Sold out |
| Bamco Inc | 0 | $0 | 0.00% | −408,563−100.0% | Sold out |
| Sumitomo Mitsui Trust Holdings, Inc. | 0 | $0 | 0.00% | −368,994−100.0% | Sold out |
| Kemnay Advisory Services Inc. | 0 | $0 | 0.00% | −121,573−100.0% | Sold out |
| Mission Creek Capital Partners, Inc. | 0 | $0 | 0.00% | −111,850−100.0% | Sold out |
| Spouting Rock Asset Management, LLC | 0 | $0 | 0.00% | −90,203−100.0% | Sold out |
| StepStone Group LP | 0 | $0 | 0.00% | −59,763−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −42,851−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −34,166−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −26,001−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −22,842−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −16,065−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −15,880−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −12,050−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −4,510−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −4,480−100.0% | Sold out |
| Baldwin Brothers Inc | 0 | $0 | 0.00% | −2,751−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |